Skip to content

Comparing the efficacy of Transforaminal epidural steroids to peripheral nerve blocks in patients with lumbar radiculopathy

EFFICACY OF PERIPHERAL NERVE BLOCKS VS TRANSFORAMINAL EPIDURAL INJECTION IN PATIENTS WITH LUMBAR RADICULOPATHY: AN EXPLORATORY OPEN LABELLED RANDOMISED CONTROL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053138
Enrollment
60
Registered
2023-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures Health Condition 2: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

Intervention1: Peripheral Nerve Block: For L5 radiculopathy Deep peroneal nerve block/posterior tibial nerve block with 4 ml of Bupivacaine (0.25%) with Methylprednisolone 80 mg (Total volume - 5ml) F

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age more than 18 years. 2. History of segmental low back pain of lumbar or sacral origin with radiation to the unilateral lower limb below the knee of more than 3 months duration. 3. History of predominant leg pain over back pain. 4. Radicular pain not responding to oral medications and physiotherapy. 5. Pain involving up to two segmental levels (L4, L5 and S1). 6. Average pain score of >=5 on an 11-point NRS. 7. Tenderness over the concordant peripheral nerves (Gore sign +) 8. Lower limb pain centralizes to spine on extension (McKenzeâ??s test +) 9. Computed tomography/Magnetic resonance imaging evidence of nerve root pain concordant with the side and level of clinical features. 10. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient refusal to participate. 2. Coagulopathy and/or patients on anticoagulants. 3. Infection at the site of injection. 4. Hypersensitivity to local anesthetic agent. 5. Evidence of significant sensory or progressive motor deficit. 6. Evidence of severe psychiatric illness. 7. Presence of cancer as a cause of back pain. 8. Presence of diabetes mellitus, multiple sclerosis, cardiac pacemaker, pregnancy.

Design outcomes

Primary

MeasureTime frame
1.A reduction in pain as measured by â?¥50% or â?¥4 point reduction in an 11-point numeric scale (NRS 0-10).Timepoint: at 2 weeks

Secondary

MeasureTime frame
Analgesic requirements according to medication quantification scaleTimepoint: at 2 weeks, 1 month, 2 months and 3 months;To compare Global Perceived EffectTimepoint: at 2 weeks, 1 month, 2 months and 3 months.;To compare improvement in functional status as measured by Modified Oswestry Disability Questionnaire (MODQ)Timepoint: at 2 weeks, 1 month, 2 months and 3 months.;To compare the pain scores (NRS-11). Timepoint: immediate post procedure, 1 month, 2 months and 3 months.

Countries

India

Contacts

Public ContactPradeep Atter

All India Institute of Medical Sciences

praveenrt64@gmail.com9654162941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026